Unknown

Dataset Information

Molecular alterations and prognosis of breast cancer with cutaneous metastasis.


ABSTRACT:

Purpose

Cutaneous metastasis (CM) accounts for 5-30% of patients with breast cancer (BC) and presents unfavorable response to treatment and poor prognosis. A better understanding of the molecular alterations involved in metastasis is essential, which would help identify diagnostic and efficacy biomarkers for CM.

Materials

We retrospectively reviewed a total of 13 patients with histological or cytological diagnosis of breast cancer and CM. Clinical information was extracted from the medical records. The mutational landscape of matched primary tumors with their lymph nodes or CM tissues were analyzed using next-generation sequencing (NGS) of 425 cancer-relevant genes. All tissues were also analyzed by immunohistochemistry (IHC). The association of prognosis with various clinic

SUBMITTER: Xu Y 

PROVIDER: S-EPMC11225245 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature